This Groundbreaking Smartphone Test Could Reveal Your Parkinson's Risk—Don't Ignore It!

Groundbreaking research is paving the way for early detection of Parkinson's disease (PD) through the use of everyday smartphone motion data, offering a more accessible method for screening dopamine deficiency without exposing patients to radiation.

Parkinson’s disease is a progressive neurodegenerative disorder primarily characterized by the loss of dopamine-producing neurons in the brain, specifically in the nigrostriatal pathway. This disruption results in motor symptoms, impacting voluntary movement and coordination. Traditional diagnostic methods, such as dopamine transporter (DaT) single-photon emission computed tomography (SPECT), are often costly and involve radiation, making them less accessible for many patients.

A recent study published in the journal NPJ Digital Medicine explores an innovative approach that combines smartphone motion data with established clinical scores, potentially transforming the way early dopamine loss in PD is screened. The study focuses on the correlation between smartphone-based assessments and DaT scan results, aiming to provide a cost-effective and efficient alternative for early detection.

Understanding Parkinson's Diagnosis

Diagnosing dopamine deficiency in Parkinson’s disease typically involves SPECT imaging, which quantifies the striatal binding ratio (SBR) related to DaT levels in critical brain regions such as the caudate nucleus and putamen. A low SBR is indicative of significant dopaminergic neuron loss, corresponding with various motor dysfunctions and clinical symptoms measured by the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale Part III (MDS-UPDRS-III).

Parkinson’s is classified as an alpha-synucleinopathy, a condition marked by the abnormal accumulation and misfolding of the alpha-synuclein protein in neurons. Early diagnosis of prodromal forms of PD is crucial, as it can lead to timely interventions that may mitigate the disease's progression. Notably, isolated REM sleep behavior disorder (iRBD) is linked to a 6% annual risk of progressing to overt PD or dementia with Lewy bodies (DLB). Over 60% of individuals with iRBD display early signs of dopaminergic deficiency, and 30% may develop alpha-synucleinopathy within three years.

Digital tools have emerged as promising resources for screening PD. The Oxford Parkinson’s Disease Centre (OPDC) smartphone application, for example, has shown accuracy in distinguishing between healthy individuals, those with iRBD, and PD patients, while also predicting MDS-UPDRS-III motor scores.

The current study builds upon previous findings by training machine learning models on smartphone-collected data to predict DaT status and SBR. The goal is to identify individuals at higher risk for abnormal DaT scan results without requiring expensive imaging techniques.

Key Findings from the Study

The study involved 93 patients diagnosed with iRBD, PD, or neither, all of whom had undergone both a DaT scan and a smartphone-based assessment within the last year. The machine learning models derived from smartphone data achieved a discrimination rate of 80% when predicting DaT outcomes, which is comparable to the predictive ability of models based on MDS-UPDRS-III scores. When combining both data sources, the area under the curve (AUC) value reached 85%.

The logistic regression model utilizing MDS-UPDRS-III scores performed slightly better overall, with AUCs of 82% and 85% for models using either data source or both, respectively. Notably, the highest predictive values from the models were associated with gait, manual dexterity, and tremor, highlighting the sensitivity of smartphone assessments for detecting early subclinical tremors indicative of dopamine deficiency.

According to the authors, this study underscores the importance of integrating digital assessments alongside traditional clinical evaluations. They noted,

This underscores the added value of integrating digital assessments while highlighting the importance of model selection based on data complexity and dimensionality.

However, the models were less effective when applied to a logistic regression analysis focusing solely on milder PD cases. This finding suggests that motor-based assessments on their own may not be as reliable for predicting disease progression in the early stages of Parkinson's.

Despite the small sample size, the study demonstrates the feasibility of combining smartphone-based motor assessments with clinical MDS-UPDRS-III scores to predict DaT scan status in individuals with iRBD and PD. The authors concluded that if confirmed, this integrated framework could offer a widely accessible tool for pre-screening DaT imaging, thus enabling earlier intervention and more frequent monitoring for patients and clinicians alike.

This innovative approach not only has the potential to make PD screening more accessible but also emphasizes the evolving role of technology in healthcare, particularly in the realm of neurological disorders. As the landscape of PD diagnosis continues to shift, patients may soon benefit from a method that is both less invasive and more aligned with everyday life.

Journal reference: Gunter, K. M., Groenewald, K., Aubourg, T., et al. (2025). Smartphone-based prediction of dopaminergic deficit in prodromal and manifest Parkinson’s disease. NPJ Digital Medicine. DOI: 10.1038/s41746-025-02148-2. Link to study